ALEXANDER MATZ: Open Payments
NPI 1861755514 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 56 payments from 13 companies in 2025. Trend: 2023 $791 · 2024 $1,106 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $428 |
| ABBVIE INC. | 10 | $193 |
| PFIZER INC. | 4 | $82 |
| Lundbeck LLC | 3 | $66 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Impel Pharmaceuticals LLC | 2 | $41 |
| Valinor Pharma, LLC | 2 | $38 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| Averitas Pharma Inc. | 1 | $26 |
Products named: RELISTOR, UBRELVY, NURTEC ODT, QULIPTA, VYEPTI, JOURNAVX, Belbuca, TRUDHESA.
Industry payments across DE — which companies pay providers there.
